comprehensive -WSS

comprehensive

author：explore 2025-08-12 08:28:37 - browse：4375

Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT — Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Cheap, fast test for Zika and dengue could cost just $1

Wikipedia

WSS

FDA's Woodcock to retire early next year

World's first CRISPR

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

5 takeaways from STAT's examination of Zynex Medical

A daunting task: navigating dual Medicare, Medicaid eligibility

PBM reforms clear House panel

explore

comprehensive

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

In key trial, Verve's treatment lowers cholesterol levels in patients

The high cost of giving birth even with insurance

Childhood cancer progress stalls for Black, Hispanic kids: Report

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Cheap, fast test for Zika and dengue could cost just $1

In Memoriam: Notable people who died in 2023

New report analyzes digital physical therapy solutions' effectiveness

Jerome Adams on the need for new antivirals for Covid

Weight loss drug costs may need more research, senator suggests

explore

The system is set up to fail children with medical complexity

In key trial, Verve's treatment lowers cholesterol levels in patients

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Moderna says combo Covid

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Wikipedia

hotspot

knowledge

focus